TA
PBYI icon

Teachers Advisors’s Puma Biotechnology PBYI Stock Holding History

Teachers Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$8.23M Sell
212,277
-1,440
-0.7% -$44K 0.01% 1107
2018
Q4 		$4.35M Buy
213,717
+3,247
+2% +$97.5K 0.01% 1394
2018
Q3 		$9.65M Buy
210,470
+42,091
+25% +$2.03M 0.01% 1090
2018
Q2 		$9.96M Sell
168,379
-3,176
-2% -$184K 0.01% 1085
2018
Q1 		$11.7M Buy
171,555
+7,718
+5% +$578K 0.02% 966
2017
Q4 		$16.2M Sell
163,837
-14,190
-8% -$1.59M 0.02% 829
2017
Q3 		$21.3M Buy
178,027
+25,129
+16% +$2.34M 0.03% 659
2017
Q2 		$13.4M Buy
152,898
+7,701
+5% +$431K 0.02% 859
2017
Q1 		$5.4M Buy
145,197
+2,824
+2% +$103K 0.01% 1264
2016
Q4 		$4.37M Buy
142,373
+7,719
+6% +$334K 0.01% 1357
2016
Q3 		$9.03M Buy
134,654
+13,462
+11% +$681K 0.02% 985
2016
Q2 		$3.61M Buy
121,192
+101,875
+527% +$3.18M 0.01% 1322
2016
Q1 		$567K Sell
19,317
-48,543
-72% -$2.19M ﹤0.01% 2273
2015
Q4 		$5.32M Sell
67,860
-253
-0.4% -$19.9K 0.01% 1112
2015
Q3 		$5.13M Buy
68,113
+1,252
+2% +$118K 0.01% 1107
2015
Q2 		$7.81M Sell
66,861
-15,104
-18% -$2.74M 0.01% 1000
2015
Q1 		$19.4M Buy
81,965
+3,224
+4% +$689K 0.04% 587
2014
Q4 		$14.9M Sell
78,741
-438
-0.6% -$97.2K 0.03% 703
2014
Q3 		$18.9M Sell
79,179
-5,135
-6% -$1.05M 0.04% 566
2014
Q2 		$5.57M Buy
84,314
+21,641
+35% +$1.54M 0.01% 1097
2014
Q1 		$6.53M Buy
62,673
+31,061
+98% +$3.65M 0.01% 993
2013
Q4 		$3.27M Buy
31,612
+910
+3% +$53.4K 0.01% 1278
2013
Q3 		$1.65M Buy
30,702
+2,335
+8% +$126K ﹤0.01% 1612
2013
Q2 		$1.26M Buy
+28,367
New +$1M ﹤0.01% 1712

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Teachers Advisors's PBYI Position: Q1 2019 in Review

Teachers Advisors reduced its Puma Biotechnology (PBYI) stake by 0.67% in Q1 2019, selling an estimated $44K and leaving 212,277 shares worth $8.23M. The position accounts for 0.01% of the portfolio, ranked #1107.

Teachers Advisors first reported a position in PBYI in Q2 2013 and has held it in 24 quarters since. The position peaked at $21.3M in Q3 2017. 158 funds tracked by Wall St. Rank hold PBYI as of Q1 2019.

  • Teachers Advisors held 212,277 shares of Puma Biotechnology worth $8.23M as of Q1 2019.
  • Teachers Advisors sold 1,440 Puma Biotechnology shares in Q1 2019, an estimated $44K.
  • Puma Biotechnology made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1107 holding.
  • Teachers Advisors first reported a position in Puma Biotechnology in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Puma Biotechnology position peaked at $21.3M in Q3 2017.
  • 158 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.